Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANIK NASDAQ:KIDS NASDAQ:LMAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANIKAnika Therapeutics$14.88-0.9%$14.77$7.87▼$16.24$197.99M0.16134,055 shs50,841 shsKIDSOrthoPediatrics$18.37-0.3%$16.71$14.42▼$23.70$471.74M0.99163,915 shs119,451 shsLMATLeMaitre Vascular$97.75-1.8%$108.75$78.35▼$118.01$2.23B0.6219,779 shs207,218 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANIKAnika Therapeutics-0.79%-2.09%-0.13%+41.30%+28.27%KIDSOrthoPediatrics-0.38%+2.96%+13.42%+8.67%-15.65%LMATLeMaitre Vascular-1.88%+0.02%-11.06%+7.08%+22.11%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANIKAnika Therapeutics$14.88-0.9%$14.77$7.87▼$16.24$197.99M0.16134,055 shs50,841 shsKIDSOrthoPediatrics$18.37-0.3%$16.71$14.42▼$23.70$471.74M0.99163,915 shs119,451 shsLMATLeMaitre Vascular$97.75-1.8%$108.75$78.35▼$118.01$2.23B0.6219,779 shs207,218 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANIKAnika Therapeutics-0.79%-2.09%-0.13%+41.30%+28.27%KIDSOrthoPediatrics-0.38%+2.96%+13.42%+8.67%-15.65%LMATLeMaitre Vascular-1.88%+0.02%-11.06%+7.08%+22.11%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANIKAnika Therapeutics 2.00Hold$17.0014.25% UpsideKIDSOrthoPediatrics 2.82Moderate Buy$24.4433.07% UpsideLMATLeMaitre Vascular 2.75Moderate Buy$112.6015.19% UpsideCurrent Analyst Ratings BreakdownLatest LMAT, KIDS, and ANIK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)5/6/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/6/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$105.00 ➝ $120.005/6/2026LMATLeMaitre Vascular Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$118.00 ➝ $127.005/6/2026LMATLeMaitre Vascular Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$94.00 ➝ $104.005/1/2026KIDSOrthoPediatrics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$17.005/1/2026KIDSOrthoPediatrics BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$24.004/24/2026KIDSOrthoPediatrics Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$25.004/21/2026KIDSOrthoPediatrics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026LMATLeMaitre Vascular Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy3/31/2026LMATLeMaitre Vascular Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANIKAnika Therapeutics$116.26M1.70N/AN/A$10.06 per share1.48KIDSOrthoPediatrics$236.35M2.00$0.17 per share111.25$13.19 per share1.39LMATLeMaitre Vascular$256.28M8.72$2.80 per share34.95$17.80 per share5.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANIKAnika Therapeutics-$10.88M-$0.79N/AN/AN/A-9.52%-5.90%-4.52%7/29/2026 (Estimated)KIDSOrthoPediatrics-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%8/4/2026 (Estimated)LMATLeMaitre Vascular$57.73M$2.7136.0729.892.8224.35%15.36%9.78%8/4/2026 (Estimated)Latest LMAT, KIDS, and ANIK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026LMATLeMaitre Vascular$0.66$0.68+$0.02$0.68$66.67 million$66.55 million4/30/2026Q1 2026KIDSOrthoPediatrics-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million4/29/2026Q1 2026ANIKAnika Therapeutics-$0.07$0.27+$0.34-$0.37$28.14 million$29.61 million2/26/2026Q4 2025ANIKAnika Therapeutics$0.02$0.31+$0.29$0.12$28.88 million$30.62 million2/26/2026Q4 2025KIDSOrthoPediatrics-$0.37-$0.26+$0.11-$0.43$61.27 million$61.61 million2/25/2026Q4 2025LMATLeMaitre Vascular$0.67$0.68+$0.01$0.68$62.98 million$64.45 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthANIKAnika TherapeuticsN/AN/AN/AN/AN/AKIDSOrthoPediatricsN/AN/AN/AN/AN/ALMATLeMaitre Vascular$1.001.02%+16.05%36.90%14 YearsLatest LMAT, KIDS, and ANIK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/28/2026LMATLeMaitre Vascularquarterly$0.251%5/21/20265/21/20266/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANIKAnika TherapeuticsN/A4.463.37KIDSOrthoPediatrics0.295.212.37LMATLeMaitre Vascular0.4214.3212.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANIKAnika Therapeutics91.53%KIDSOrthoPediatrics69.05%LMATLeMaitre Vascular84.64%Insider OwnershipCompanyInsider OwnershipANIKAnika Therapeutics12.08%KIDSOrthoPediatrics32.70%LMATLeMaitre Vascular7.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANIKAnika Therapeutics30013.31 million11.70 millionOptionableKIDSOrthoPediatrics20025.68 million17.29 millionOptionableLMATLeMaitre Vascular49022.85 million21.16 millionOptionableLMAT, KIDS, and ANIK HeadlinesRecent News About These CompaniesThrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMATMay 21 at 4:19 AM | marketbeat.comLeMaitre to Participate at Upcoming Investor Conferences in JuneMay 20 at 4:25 PM | globenewswire.comGSA Capital Partners LLP Has $1.72 Million Position in LeMaitre Vascular, Inc. $LMATMay 20 at 3:54 AM | marketbeat.comWinners and losers of Q1: LeMaitre (NASDAQ:LMAT) vs the rest of the surgical equipment & consumables - specialty stocksMay 19 at 7:17 AM | msn.comLemaitre Vascular (LMAT) Receives a Buy from SidotiMay 19 at 1:34 AM | theglobeandmail.comLemaitre Vascular (LMAT) Gets a Hold from Wells FargoMay 19 at 1:34 AM | theglobeandmail.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 18, 2026 | marketbeat.comWakefield Asset Management LLLP Buys New Position in LeMaitre Vascular, Inc. $LMATMay 16, 2026 | marketbeat.comDown 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a TurnaroundMay 13, 2026 | zacks.comVanguard Group Inc. Boosts Stake in LeMaitre Vascular, Inc. $LMATMay 12, 2026 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Director Bridget Ross Sells 5,044 Shares of StockMay 12, 2026 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Insider Trent Kamke Sells 2,928 SharesMay 12, 2026 | insidertrades.comLeMaitre Vascular (NASDAQ:LMAT) CEO George Lemaitre Sells 27,881 SharesMay 12, 2026 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) CEO George Lemaitre Sells 18,600 Shares of StockMay 12, 2026 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Insider Trent Kamke Sells 2,928 SharesMay 11, 2026 | marketbeat.comBridget Ross Sells 5,044 Shares of LeMaitre Vascular (NASDAQ:LMAT) StockMay 11, 2026 | marketbeat.comUS$118 - That's What Analysts Think LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Worth After These ResultsMay 7, 2026 | finance.yahoo.comLeMaitre to Present at the Bank of America Healthcare ConferenceMay 7, 2026 | globenewswire.com3 Reasons Growth Investors Will Love LeMaitre (LMAT)May 7, 2026 | zacks.comLeMaitre (LMAT) Upgraded to Buy: Here's WhyMay 7, 2026 | zacks.comBarrington Research Raises LeMaitre Vascular (NASDAQ:LMAT) Price Target to $120.00May 6, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLMAT, KIDS, and ANIK Company DescriptionsAnika Therapeutics NASDAQ:ANIK$14.88 -0.14 (-0.93%) Closing price 04:00 PM EasternExtended Trading$14.88 +0.00 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.OrthoPediatrics NASDAQ:KIDS$18.37 -0.06 (-0.33%) Closing price 04:00 PM EasternExtended Trading$18.38 +0.00 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.LeMaitre Vascular NASDAQ:LMAT$97.75 -1.77 (-1.78%) Closing price 04:00 PM EasternExtended Trading$97.69 -0.06 (-0.06%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
